This is consistent with our previous study in a cohort of 527 breast cancer patients which showed that high expression of cytoplasmic STAT3 was associated with reduced outcome while low expression of nuclear STAT3 was associated with poor outcomes [27]. This evidence concerns the gene STAT3 and breast carcinoma.